NO20074762L - Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter - Google Patents

Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter

Info

Publication number
NO20074762L
NO20074762L NO20074762A NO20074762A NO20074762L NO 20074762 L NO20074762 L NO 20074762L NO 20074762 A NO20074762 A NO 20074762A NO 20074762 A NO20074762 A NO 20074762A NO 20074762 L NO20074762 L NO 20074762L
Authority
NO
Norway
Prior art keywords
endometriosis
identification
value
blood lymphocytes
diagnostic markers
Prior art date
Application number
NO20074762A
Other languages
English (en)
Norwegian (no)
Inventor
Idhaliz Flores
Spyro Mousses
Ester Rozenblum
Original Assignee
Ponce School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponce School Of Medicine filed Critical Ponce School Of Medicine
Publication of NO20074762L publication Critical patent/NO20074762L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20074762A 2005-02-18 2007-09-18 Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter NO20074762L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65433105P 2005-02-18 2005-02-18
PCT/US2005/044723 WO2006091254A1 (en) 2005-02-18 2005-12-09 Identification of molecular diagnostic markers for endometriosis in blood lymphocytes

Publications (1)

Publication Number Publication Date
NO20074762L true NO20074762L (no) 2007-11-16

Family

ID=36182367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074762A NO20074762L (no) 2005-02-18 2007-09-18 Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter

Country Status (13)

Country Link
US (1) US20090208939A1 (enExample)
EP (1) EP1848818A1 (enExample)
JP (1) JP2008537474A (enExample)
KR (1) KR20080016789A (enExample)
CN (1) CN101124340A (enExample)
AU (1) AU2005327929A1 (enExample)
BR (1) BRPI0520012A2 (enExample)
CA (1) CA2596932A1 (enExample)
IL (1) IL184920A0 (enExample)
MX (1) MX2007009562A (enExample)
NO (1) NO20074762L (enExample)
WO (1) WO2006091254A1 (enExample)
ZA (1) ZA200707752B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9222938B2 (en) * 2001-12-04 2015-12-29 Michael Tainsky Neoepitope detection of disease using protein arrays
WO2008123901A2 (en) * 2007-02-06 2008-10-16 Genizon Biosciences Genemap of the human genes associated with endometriosis
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
WO2009140126A1 (en) * 2008-05-14 2009-11-19 Juneau Biosciences, Llc Method of administering a therapeutic
WO2010124101A2 (en) 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
JP5503942B2 (ja) * 2009-10-30 2014-05-28 シスメックス株式会社 疾患の罹患の判定方法
EP2348129A1 (en) * 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
KR101333207B1 (ko) * 2011-07-13 2013-11-26 부산대학교 산학협력단 자궁내막증과 연관된 유전자 마커 및 이의 용도
EP2773779B1 (en) 2011-11-04 2020-10-14 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
WO2013120018A1 (en) 2012-02-09 2013-08-15 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
KR101445560B1 (ko) 2012-05-10 2014-09-29 한국수력원자력 주식회사 저준위 전리방사선에 민감한 유전자 검출 방법 및 상기 방법으로 검출된 유전자
DK2895621T3 (da) 2012-09-14 2020-11-30 Population Bio Inc Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
JP2016526888A (ja) * 2013-06-28 2016-09-08 アキュメン リサーチ ラボラトリーズ プライヴェット リミテッドAcumen Research Laboratories Pte. Ltd. 敗血症バイオマーカー及びそれらの使用
EP3511422B1 (en) 2013-11-12 2022-12-28 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating endometriosis
DE102014203235A1 (de) * 2014-02-24 2015-08-27 Mahle International Gmbh Klimagerät, insbesondere für ein Kraftfahrzeug und Verfahren zur Herstellung einer Komponente eines Klimagerätes
RU2558854C1 (ru) * 2014-06-23 2015-08-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития эндометриоза
JP2016077234A (ja) * 2014-10-17 2016-05-16 国立大学法人鳥取大学 子宮内膜症の早期診断のための診断キット、診断マーカー及び検出方法
CN107326065B (zh) * 2016-04-29 2022-07-29 博尔诚(北京)科技有限公司 一种基因标识物的筛选方法及其应用
CN107858415B (zh) * 2016-09-19 2021-05-28 深圳华大生命科学研究院 用于子宫腺肌症检测的生物标志物组合及其应用
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
US10729693B2 (en) * 2018-03-02 2020-08-04 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis
CN108456723A (zh) * 2018-03-21 2018-08-28 福州福瑞医学检验实验室有限公司 一种子宫内膜异位症风险预测的基因检测引物和试剂盒
EP3781945A4 (en) * 2018-04-20 2022-04-27 The Board of Regents of the University of Texas System COMPOSITIONS AND METHODS FOR TREATMENT OF ENDOMETRIOSIS
US11906529B1 (en) * 2018-04-27 2024-02-20 Marshall University Research Corporation Methods for treatment and diagnosis of endometriosis
CA3108807A1 (en) 2018-08-08 2020-02-13 Pml Screening, Llc Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
WO2024263816A2 (en) * 2023-06-21 2024-12-26 Cristcot Llc Development and validation of the hemorrhoid disease symptom impact measure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60321356D1 (de) * 2002-08-30 2008-07-10 Oncotherapy Science Inc Verfahren zur diagnostik von eierstock endometriose

Also Published As

Publication number Publication date
EP1848818A1 (en) 2007-10-31
IL184920A0 (en) 2007-12-03
US20090208939A1 (en) 2009-08-20
JP2008537474A (ja) 2008-09-18
AU2005327929A1 (en) 2006-08-31
BRPI0520012A2 (pt) 2009-04-14
WO2006091254A1 (en) 2006-08-31
CN101124340A (zh) 2008-02-13
MX2007009562A (es) 2008-03-11
KR20080016789A (ko) 2008-02-22
ZA200707752B (en) 2010-05-26
CA2596932A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
NO20074762L (no) Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter
Nallagangula et al. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression
Stearman et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model
WO2005095644A3 (de) Verfahren zur erkennung von signaturen in komplexen genexpressionsprofilen
ES2640532T3 (es) Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello
MX2007009427A (es) Metodo diagnostico de la esteatosis hepatica utilizando marcadores bioquimicos.
NO20070598L (no) Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem
WO2016050111A1 (en) Biomarkers for rheumatoid arthritis and usage thereof
Belcher et al. Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury
EP2339348A3 (en) Method for diagnosing neuro-degenerative disease
WO2009126969A3 (en) Biomarkers for endometrial disease
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
US20160252512A1 (en) Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
MX2008011665A (es) Diagnóstico y pronóstico de los estados patológicos asociados a la dipeptidil-peptidasa.
Hinkelbein et al. Alterations in cerebral metabolomics and proteomic expression during sepsis
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
Talla et al. Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing
Haq et al. Identification of specific biomarkers for anaplastic thyroid carcinoma through spatial transcriptomic and immunohistochemical profiling
WO2008116178A8 (en) Systems and methods for diagnosis and prognosis of colorectal cancer
WO2007103211A3 (en) Methods to identify fat and lean animals using class predictors
Taylor et al. Aminopeptidase activities as prospective urinary biomarkers for bladder cancer
Paziewska et al. Mass Spectrometry‐Based Comprehensive Analysis of Pancreatic Cyst Fluids
KR101594980B1 (ko) 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application